Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Novo Nordisk vill köpa fransk samarbetspartner

Danska Novo Nordisk har inlett förhandlingar med medtech-företaget Biocorps största ägare om att förvärva samtliga av dess aktier i bolaget. Om affären går i lå...

Dansk-svenskt samarbete kring antibiotikaresistens i EU

Ett europeiskt referenslaboratorium för antibiotikaresistens ska etableras genom ett samarbete mellan Danmark och Sverige. Laboratoriet ska bidra med kunskap kr...

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

The life science strategy – what the industry wants

The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

Sustainability at Festo

On the Way to the Net Zero Era - New Sustainability Report published

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Novo Nordisk sues compounding pharmacies in the US

Novo Nordisk is suing compounding pharmacies in Florida, USA, because the company claims to have found impurities in the active ingredient in the obesity drug Wegovy.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Vi ställer ut på Nordic Future Food 2022.

Boka in 11-12 maj på Kistamässan

A mass flow controller that is silent, fast and cost-effective

Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Nanexa får två ordrar för detektion av kärnvapensprängningar

De två ordrarna från amerikanska försvars- och rymdindustrin är värda 1,7 miljoner kronor.

Nanexa ingår avtal med Novo Nordisk om 46 miljoner

Klaria i spanskt samarbete om munfilm från alger

Uppsalabaserade Klaria Pharma har tecknat avtal med det spanska läkemedelsbolaget Pharmamar om utveckling av en alginatfilmsformulering till en av Pharmamars su...

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Rickard Sandberg om årets Nobelpris i medicin: ”En nyckelupptäckt”

Upptäckten som banade väg för utvecklingen av dagens mRNA-vacciner ligger till grund för årets Nobelpris i fysiologi eller medicin.

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Life science trends 2025 – Neurology

New Alzheimer's drugs are beginning to be used in Sweden, more deals in the neuro sector are expected, and tools for deliver active substances across the blood-...

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Diabetes drug tirzepatide has now also been approved in the US for treating obesity.

Rickard Sandberg on this year’s Nobel Prize in Medicine: ”A key discovery”

The discovery that paved the way for the development of todays mRNA vaccines is the basis for this year’s Nobel Prize in Physiology or Medicine.

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...